The Royal Marsden NHS Foundation Trust

As the first hospital in the world dedicated to cancer, The Royal Marsden remains a global titan in drug development and immune-oncology. Their specialized immunotherapy unit focuses on “checkpoint inhibitors” and “cancer vaccines,” utilizing molecular profiling to predict which patients will respond best to specific biological agents. They lead a vast array of international clinical trials, often providing access to treatments years before they become standard care.